Vertaling van "king by pfizer " (Frans → Nederlands) :

TERMINOLOGIE

virus Mason-Pfizer du singe
Mason-Pfizer apenvirus

IN-CONTEXT TRANSLATIONS

Actual results could differ materially from those currently anticipated due to a number of risks and uncertainties. Risks and uncertainties related to the acquisition of King by Pfizer that could cause results to differ from expectations include: uncertainties as to the timing of the merger; the possibility that a governmental entity may prohibit or delay the consummation of the merger; and the risk of shareholder litigation, including the disposition of currently pending litigation, in connection with the merger.
Actual results could differ materially from those currently anticipated due to a number of risks and uncertainties.

King’s three key businesses are not only complementary to Pfizer’s businesses, but are also strategically aligned with Pfizer’s Primary Care, Established Products and Animal Health business units, enabling a seamless combination that will maximize King’s assets with Pfizer’s global organization’s scale and resources.
King’s three key businesses are not only complementary to Pfizer’s businesses, but are also strategically aligned with Pfizer’s Primary Care, Established Products and Animal Health business units, enabling a seamless combination that will maximize King’s assets with Pfizer’s global organization’s scale and resources.

Pfizer Completes Tender Offer For Shares Of King Pharmaceuticals, Inc.
Pfizer Completes Tender Offer For Shares Of

Pfizer Extends Tender Offer To Acquire King Pharmaceuticals, Inc. to January 28, 2011
King Pharmaceuticals, Inc. to January 28, 2011